Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Aug 7, 2008; 14(29): 4677-4683
Published online Aug 7, 2008. doi: 10.3748/wjg.14.4677
Published online Aug 7, 2008. doi: 10.3748/wjg.14.4677
Parameter | HF (n = 9) | Control (n = 7) | P |
Body weight (g) | 560.76 ± 5.59 | 482.37 ± 10.19 | < 0.001 |
Liver | |||
TC (mg/dL ) | 0.42 ± 0.04 | 0.46 ± 0.02 | |
TG (mg/dL) | 0.89 ± 0.07 | 0.64 ± 0.07 | 0.023 |
Plasma | |||
GLU (mg/dL) | 9.18 ± 0.32 | 7.84 ± 0.15 | 0.004 |
TG (mg/dL) | 0.98 ± 0.12 | 0.36 ± 0.16 | < 0.001 |
TC (mg/dL) | 1.72 ± 0.11 | 1.39 ± 0.11 | |
LDL-C (mg/dL) | 0.35 ± 0.03 | 0.18 ± 0.03 | 0.001 |
HDL-C (mg/dL) | 0.96 ± 0.06 | 0.90 ± 0.05 | |
ALT (U/L) | 58.11 ± 4.09 | 43.71 ± 3.17 | 0.019 |
AST (U/L) | 70.22 ± 2.31 | 70.86 ± 4.76 |
- Citation: Zhu MJ, Sun LJ, Liu YQ, Feng YL, Tong HT, Hu YH, Zhao Z. Blood F2-isoprostanes are significantly associated with abnormalities of lipid status in rats with steatosis. World J Gastroenterol 2008; 14(29): 4677-4683
- URL: https://www.wjgnet.com/1007-9327/full/v14/i29/4677.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.4677